There is not enough evidence to back a claim that olive leaf water extract boosts glucose tolerance, a European Food Safety Authority (EFSA) health claims panel has found.
The panel on Dietetic Products, Nutrition and Allergies (NDA) was asked its opinion after an application from Comvita New Zealand Limited in September.
The natural health products company had proposed the claim that, “daily intake of supplemental olive leaf extract polyphenols contributes to the reduction of the blood glucose rise after meals.” It proposed a daily intake of five of its OLE (olive leaf extract) capsules, each containing 400 mg
OLE, in order to provide at least 50mg daily of oleuropein. Comvita said the target population was adults willing to reduce their postprandial (after eating) glycemic response. “It will be particularly beneficial to individuals with impaired glucose tolerance, a common condition in the general adult population, particularly among those who are overweight or obese,” it told EFSA.
Comvita identified two human studies and three animal studies as being pertinent to the claim but in an opinion published earlier this month, the NDA panel said no conclusion could be drawn from one of the human studies and the three animal studies as they involved foods not complying with Comvita’s specifications.
It said the other human study shows an increase in glucose tolerance applicant but the results have not been replicated in other studies and no evidence had been provided on the mechanism by which the olive leaf water extract could exert the claimed effect. “The scientific evidence is insufficient to establish a cause and effect relationship between the consumption of olive leaf water extract and an increase in glucose tolerance.”
Related Articles
Apr. 12, 2024
Global Production May Exceed Expectations, but Not Enough to Move Prices
Analysts predict climate change will result in new price dynamics, with high-quality extra virgin olive oil and other market segments behaving differently.
Dec. 5, 2024
Trump Health Secretary Pick Elevates Seed Oil Controversy to U.S. Cabinet
Robert F. Kennedy Jr. has long railed against seed oils. If confirmed as the Secretary of Health and Human Services, he will be in a position to regulate the industry.
Jan. 8, 2024
Mediterranean Diet Tops List for Seventh Year
The U.S. News & World Report cited the diet's variety, flexibility and health benefits.
Apr. 22, 2024
How Oleuropein Influences Extra Virgin Olive Oil Taste and Health Benefits
Along with oleocanthal and hydroxytyrosol, oleuropein is one of the main polyphenols found in extra virgin olive oil that determines its sensory characteristics and health benefits.
Jan. 15, 2024
Oleocanthal: Behind the Health Benefits of Olive Oil's Famous Phenol
Found solely in extra virgin olive oil, oleocanthal demonstrates potent anti-inflammatory properties and has been linked to beneficial impacts on cancer and dementia.
Jul. 18, 2024
Despite Falling Prices at Origin, Olive Oil Retail Prices Remain Elevated
Various factors contribute to persistently high olive oil prices at retail, including market structure, speculation and resilient global demand.
Oct. 18, 2024
European Union Olive Oil Production Set to Grow by One-Third
Brussels’ autumn short-term outlook predicts volatile prices.
Mar. 6, 2024
Europe Strengthens Protections for Geographical Indications
The reforms provide protection for PDO and PGI extra virgin olive oil from online fraud and ease the process of registering new ones with the European Commission.